Use of Atypical Antipsychotics in Prolonged Mechanical Ventilation Related Anxiety
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Case Description

Introduction
Emory Long Term Acute Care (LTAC) hospital admits patients from other

A 57-year-old African American female presented to an acute care hospital

hospitals in Georgia for prolonged mechanical ventilation (PMV) weaning. A

with chronic hypercapnic respiratory failure with a past medical history of

multidisciplinary team developed a protocol for PMV weaning which begins

asthma, chronic obstructive pulmonary disease, diastolic heart failure,

on admission and continues to decannulation. Within this protocol, anxiety

acute kidney failure, obstructive sleep apnea, hypertension, and type 2

must be assessed and treated in responsive patients. Previous research

diabetes. She was noted to be in hypercapnic respiratory failure and was

suggests that mechanical ventilation induced anxiety can be a contributing
factor to the patient’s inability to be weaned off ventilator support. Emory

initially treated with Bilevel Positive Airway Pressure (BiPAP) therapy and

LTAC Hospital uses Geodon®, a second-generation antipsychotic, to

admitted to the ICU. In the ICU, her respiratory status worsened despite

reduce anxiety in patients on PMV. The use of Geodon® has significantly

BiPAP therapy, requiring her to be intubated and placed on mechanical

increased ventilator weaning rates. Per the PMV protocol, the patient’s

ventilation. She was unable to wean from the ventilator and was

anxiety score is evaluated on the third day of admission. If the patient has

transferred to Emory LTAC Hospital.

an anxiety score of 7 or greater, an order for Geodon® 20mg PO, PT or IM
BID

is

initiated.

Other

antipsychotics,

such

as

quetiapine,

The patient’s anxiety score was assessed using a modified Beck Anxiety

and

Inventory (BAI) scale.

benzodiazepines have been used to reduce ventilator associated anxiety,

• Day 3 of hospitalization revealed a score of 8. (Graph1).

but the results were not as effective because these medications do not
reduce anxiety as well and take longer to take effect. Research suggests

- An anxiety score of 7 or greater represents significant anxiety,

that anxiety can be a potential barrier in weaning patients off mechanical

requiring the need of ziprasidone 20mg twice daily (Figure1-b).

ventilation, and with the help of Geodon® there has been better ventilator

• On Day 4 the patient received Geodon® 20mg IM twice daily for 3 days

weaning rates within our patient population.

Objective:

• One of the biggest barriers to weaning ventilator patients in a long term

followed by Geodon® 20mg by mouth twice daily for 29 days.

Figure 1: a) Disease Specific Certified in Respiratory Failure. b) The
- She weaned off the ventilator on day 5.
protocol approved for weaning patients from Prolonged Mechanical
Ventilation at LTAC- Day 1.
• On Day 6, mechanical ventilation was reestablished and therapy

acute care hospital is identifying and treating anxiety. This report details

continued

the second case published using Geodon® to assist in reducing anxiety

gastronomy (PEG) tube twice daily for 10 days then Geodon® 20mg by

Anxiety rating score by day

to assist in weaning a patient off prolonged mechanical ventilation.

with

Geodon®

20mg

via

percutaneous

endoscopic

mouth twice daily for 18 days.
During her last course of therapy, she was able to be taken off mechanical

9

Summary and Conclusions

ventilation support permanently. Her anxiety score decreased while being
8

treated with Geodon® represented by a total score of 3 on day 7 and 2 on

8

• In this case, the use of Geodon® allowed reduction of anxiety that

day 15 of hospitalization (graph 1). She did not receive any other anxiety

7

was prohibiting the patient from weaning in a state of prolonged
6

medications during her hospitalization. After a course of monitoring, the

5

patient no longer required mechanical ventilation and was discharged to a

mechanical ventilation. This facility has used Geodon® for ten years
as a major advancement in improving PMV patient outcomes and
ventilator weaning rates which promoted the facility receiving The

rehabilitation center.
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Graph 1: Anxiety rating scale results showed a total score of 8 on day 3,
score of 3 on day 7, which fell to a score of 2 on day 15 of admission
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